This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Exactech, Inc., Advita Ortho, LLC. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: The Innovative Contributions of Cyril Hamad
Introduction
Cyril Hamad is a notable inventor based in Meylan, France. He has made significant contributions to the field of personalized implant planning, particularly in the context of total joint arthroplasty. With a total of 3 patents to his name, his work focuses on enhancing surgical outcomes through advanced technology.
Latest Patents
Cyril Hamad's latest patents include groundbreaking methods for personalized implant planning during total joint arthroplasty. One of his patents describes a computer-based platform that utilizes patient-specific data to create a tailored surgical plan for implanting devices into a patient's joint. This method involves obtaining various patient-specific data prior to surgery and employing algorithms to prioritize functional parameters. Another patent outlines a system that generates a surgical plan based on a surgeon's profile, implant specifications, and desired post-surgery outcomes. This innovative approach aims to improve the functional performance of the joint post-implantation.
Career Highlights
Throughout his career, Cyril has worked with reputable companies such as Exactech, Inc. and Advita Ortho, LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of orthopedic surgery.
Collaborations
Cyril has collaborated with talented professionals in his field, including Laurent Angibaud and Prudhvi Chinimilli. These partnerships have contributed to the advancement of his research and the successful implementation of his patented technologies.
Conclusion
Cyril Hamad's contributions to personalized implant planning represent a significant advancement in orthopedic surgery. His innovative patents and collaborative efforts continue to shape the future of joint arthroplasty.